Rating History for Calliditas Therapeutics (CALT) by Citi
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/31/2024 | Yigal Nochomovitz | Downgrade | Neutral (Buy) |
39.00 (30.00) |
37.94 (40.00) |
5.43% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/31/2024 | Yigal Nochomovitz | Downgrade | Neutral (Buy) |
39.00 (30.00) |
37.94 (40.00) |
5.43% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||